Moderna is suing fellow vaccine developers Pfizer and its German partner BioNTech, accusing it of infringing on patents related to mRNA technology used in their COVID-19 vaccine, the company ...

Moderna sued Pfizer and BioNTech in U.S. and German courts Friday, accusing the vaccine competitors of copying its messenger RNA technology that was the novel basis for Covid vaccines. The company ...

BioNTech SE (NASDAQ:BNTX) just released its full-year report and things are looking bullish. Results overall were credible, with revenues arriving 3.9% better than analyst forecasts at €2.8b ...

Aug 6 (Reuters) - The University of Pennsylvania has sued German biotechnology firm BioNTech (22UAy.DE), opens new tab in Pennsylvania federal court, accusing the company of underpaying royalties ...

Shares of BioNTech fell 5.7% on Monday. Vaccine stocks are volatile after Moderna’s updated revenue guidance for 2025, which fell below analyst expectations. Get stock picks, daily rankings ...

In recent months, BioNTech has made significant strides in its oncology pipeline. The company's B7-H3 ADC, BNT324, has shown promising results in Phase 1/2 trials for patients with solid tumors ...

Trials of cutting-edge cancer vaccines could kick off in the U.K. as soon as September, German Covid vaccine maker BioNTech announced on Friday, part of a new government partnership to fast track ...

"BioNTech expects to grow its topline again in 2025," it said in a statement. BioNTech's German traded shares were down 0.9% at 1235 GMT as the target for this year fell short of an average ...

BioNTech is bolstering its artificial intelligence and machine learning capabilities through the £362 million acquisition of InstaDeep, a startup whose technology has already supported the ...

Development of a cancer vaccine may be accelerated by BioNTech's COVID work. LONDON -- The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer ...

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that ...